Good manufacturing practices

Size: px
Start display at page:

Download "Good manufacturing practices"

Transcription

1 The rules governing medicinal products in the European Union Volume 4 Good manufacturing practices Medicinal products for human and veterinary use 1998 Edition EUROPEAN COMMISSION Directorate General III Industry Pharmaceuticals and cosmetics

2 THE RULES GOVERNING MEDICINAL PRODUCTS IN THE EUROPEAN UNION Volume 1 Pharmaceutical legislation Medicinal products for human use Volume 2 Notice to applicants Medicinal products for human use Volume 3 Guidelines Medicinal products for human use Volume 4 Good manufacturing practices Medicinal products for human and veterinary use Volume 5 Pharmaceutical legislation Veterinary medicinal products Volume 6 Notice to applicants Veterinary medicinal products Volume 7 Guidelines Veterinary medicinal products Volume 8 Maximum residue limits Veterinary medicinal products Volume 9 Pharmacovigilance Medicinal products for human and veterinary use

3 FOREWORD The Pharmaceutical Industry of the European Community maintains high standards of Quality Assurance in the development, manufacture and control of medicinal products. A system of Marketing Authorisations ensures that all medicinal products are assessed by a Competent Authority to ensure compliance with contemporary requirements of safety, quality and efficacy. A system of Manufacturing Authorisations ensures that all products authorised on the European market are manufactured only by authorised manufacturers, whose activities are regularly inspected by the Competent Authorities. Manufacturing Authorisations are required by all pharmaceutical manufacturers in the European Community whether the products are sold within or outside of the Community. Two directives laying down principles and guidelines of good manufacturing practice (GMP) for medicinal products were adopted by the Commission in 1991, the first for medicinal products for human use (Directive 91/356/EEC), the second one for veterinary use (Directive 91/412/EEC). Detailed guidelines in accordance with those principles are published in the Guide to Good Manufacturing Practice which will be used in assessing applications for Manufacturing authorisations and as a basis for inspection of manufacturers of medicinal products. The principles of GMP and the detailed guidelines are applicable to all operations which require the authorisation referred to in Article 16 of Directive 75/319/EEC and in Article 24 of Directive 81/851/EEC as modified. They are also relevant for all other large scale pharmaceutical manufacturing processes, such as that undertaken in hospitals, and for the preparation of products for use in clinical trials. All Member States and the Industry itself are agreed that the GMP requirements applicable to the manufacture of veterinary medicinal products are the same as those applicable to the manufacture of medicinal products for human use. Certain detailed adjustments to the GMP guidelines are set out in two annexes specific to veterinary medicinal products and to immunological veterinary medicinal products. The Guide is presented in chapters, each headed by a principle. Chapter 1 on Quality Management outlines the fundamental concept of Quality Assurance as applied to the manufacture of medicinal products. Thereafter each chapter has a principle outlining the Quality Assurance objectives of that chapter and a text which provides sufficient detail for manufacturers to be made aware of the essential matters to be considered when implementing the principle. In addition to the general matters of Good Manufacturing Practice outlined in the 9 chapters of this guide, a series of annexes providing detail about specific areas of activity is included. For some manufacturing processes, different annexes will apply simultaneously (e.g. annex on sterile preparations and on radiopharmaceuticals and/or on biological medicinal products). iii

4 Foreword A glossary of some terms used in the Guide has been incorporated after the annexes. The first edition of the Guide was published in 1989, including an annex on the manufacture of sterile medicinal products. The second edition was published in January 1992; including the Commission Directives 91/356 of 13 June 1991 and 91/412 of 23 July 1991 laying down the principles and guidelines on good manufacturing practice for medicinal products for human use as well as for veterinary medicinal products. The second edition also included 12 additional annexes. The basic requirements in the main guide have not been modified. 14 annexes on the manufacture of medicinal products have been included in this third edition. Annex 1 on the manufacture of sterile medicinal products has been modified. Annex 13 on the manufacture of investigational medicinal products, which was not included in the second edition of the Guide, has been modified and included in this version. Annex 14 on the manufacture of products derived from human blood or human plasma, which was not included in the second edition of the Guide, has been included in this version and a revision is scheduled for The Guide is not intended to cover security aspects for the personnel engaged in manufacture. This may be particularly important in the manufacture of certain medicinal products such as highly active, biological and radioactive medicinal products, but they are governed by other provisions of Community or national law. Throughout the Guide it is assumed that the requirements of the Marketing Authorisation relating to the safety, quality and efficacy of the products, are systematically incorporated into all the manufacturing, control and release for sale arrangements of the holder of the Manufacturing Authorisation. The manufacture of medicinal products has for many years taken place in accordance with guidelines for Good Manufacturing Practice and the manufacture of medicinal products is not governed by CEN/ISO standards. Harmonised standards as adopted by the European standardisation organisations CEN/ISO may be used at industry s discretion as a tool for implementing a quality system in the pharmaceutical sector. The CEN/ISO standards have been considered but the terminology of these standards has not been implemented in this third edition of the Guide. It is recognised that there are acceptable methods, other than those described in the Guide, which are capable of achieving the principles of Quality Assurance. The Guide is not intended to place any restraint upon the development of any new concepts or new technologies which have been validated and which provide a level of Quality Assurance at least equivalent to those set out in this Guide. It will be regularly revised. iv

5 TABLE OF CONTENTS Foreword... DIRECTIVES... 1 Commission Directive 91/356/EEC of 13 June 1991 laying down the principles and guidelines of good manufacturing practice for medicinal products for human use... 3 Commission Directive 91/412/EEC of 23 July 1991 laying down the principles and guidelines of good manufacturing practice for veterinary medicinal products iii GOOD MANUFACTURING PRACTICES BASIC REQUIREMENTS CHAPTER 1: QUALITY MANAGEMENT Principle Quality Assurance Good Manufacturing Practice for Medicinal Products Quality Control CHAPTER 2: PERSONNEL Principle General Key Personnel Training Personnel Hygiene CHAPTER 3: PREMISES AND EQUIPMENT Principle Premises General Production Area Storage Area Quality Control Area Ancillary Areas Equipment CHAPTER 4: DOCUMENTATION Principle General Documents Required Specifications Specifications for starting and packaging materials Specifications for Intermediate and Bulk Products v

6 Table of contents Specifications for Finished Products Manufacturing Formulae and Processing Instructions Packaging Instructions Batch Processing Records Batch Packaging Records Procedures and Records Receipt Sampling Testing Other CHAPTER 5: PRODUCTION Principle General Prevention of Cross-contamination in Production Validation Starting Materials Processing Operations: Intermediate and Bulk Products Packaging Materials Packaging Operations Finished Products Rejected, Recovered and Returned Materials CHAPTER 6: QUALITY CONTROL Principle General Good Quality Control Laboratory Practice Documentation Sampling Testing CHAPTER 7: CONTRACT MANUFACTURE AND ANALYSIS Principle General The Contract Giver The Contract Acceptor The Contract CHAPTER 8: COMPLAINTS AND PRODUCT RECALL Principle Complaints Recalls CHAPTER 9: SELF INSPECTION Principle vi

7 Table of contents ANNEXES Annex 1 Manufacture of sterile medicinal products Principel General Isolator technology Blow/fill/seal technology Terminally sterilised products Aseptic preparation Personnel Premises Equipment Sanitation Processing Sterilisation Sterilisation by heat Moist heat Dry heat Sterilisation by radiation Sterilisation with ethylene oxide Filtration of medicinal products which cannot be sterilised in their final container Finishing of sterile products Quality control Annex 2 Manufacture of biological medicinal products for human use Scope Principle Personnel Premises and equipment Animal quarters and care Documentation Production Starting materials Seed lot and cell bank system Operating principles Quality control Annex 3 Manufacture of radiopharmaceuticals Principle Personnel Premises and equipment Production Quality control Distribution and recalls Annex 4 Manufacture of veterinary medicinal products other than immunologicals Manufacture of premixes for medicated and feedingstuffs Manufacture of ectoparasiticides Manufacture of veterinary medicinal products Retention of samples vii

8 Table of contents Sterile veterinary medicinal products Annex 5 Manufacture of immunological veterinary medicinal products Principle Personnel Premises Equipment Animals and animal houses Disinfection Waste disposal Production Starting materials Quality control Annex 6 Manufacture of medicinal gases Principle Personnel Premises and equipment Production and quality control Labelling Storage Release Annex 7 Manufacture of herbal medicinal products Principle Premises Storage areas Production area Documentation Specifications for starting materials Processing instructions Sampling Quality control Annex 8 Sampling of starting and packaging materials Principle Personnel Starting materials Packaging material Annex 9 Manufacture of liquids, creams and ointments Principle Premises and equipment Production Annex 10 Manufacture of pressurised metered dose aerosol preparations for inhalation Principle General Premises and equipment Production and quality control viii

9 Table of contents Annex Computerised systems 109 Principle Personnel Validation System Annex 12 Use of ionising radiation in the manufacture of medicinal products Introduction Responsibilities Dosimetry Validation of the process Commissioning of the plant General Gamma irradiators Electron beam irradiators Re-commissioning Premises Processing Gamma irradiators Electron beam irradiators Documentation Microbiological monitoring Annex 13 Manufacture of investigational medicinal products Introduction Glossary Quality management Personnel Premises and equipment Documentation Order Product Specification File Manufacturing Formulae and Processing Instructions Packaging instructions Labelling Instructions Manufacturing and packaging batch records Production Starting materials Manufacturing operations Principles applicable to comparator product Randomisation code Quality control Release of batches Free movement Contract manufacture and contract analysis Complaints Recalls and returns Shipping Returns Destruction Shipping ix

10 Table of contents Returns Destruction Annex 14 Manufacture of products derived from human blood or human plasma Principle Quality management Premises and equipment Blood collection Production and quality control Fractionation/purification procedures a) Precipitation methods b) Solid phase and filtration methods Retention of samples Cellular products and whole blood GLOSSARY x

GMP GUIDELINES. GMP Guides from Industry Organisations. FDA cgmp WHO GMP. cgmp Guide Drugs 21 CFR 210 GAMP. ISPE Technical Guides

GMP GUIDELINES. GMP Guides from Industry Organisations. FDA cgmp WHO GMP. cgmp Guide Drugs 21 CFR 210 GAMP. ISPE Technical Guides FDA cgmp cgmp Guide Drugs 21 CFR 210 cgmp Guide Drugs 21 CFR 211 cgmp Guide Medical Device 21 CFR 808, 812, 820 cgmp Guide Biologics 21 CFR 600, 606, 610 Guideline List Human Drugs Guideline List Biologics

More information

AUSTRALIAN CODE OF GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS

AUSTRALIAN CODE OF GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS Therapeutic Goods Administration AUSTRALIAN CODE OF GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS 16 August 2002 This Code is based entirely on the Guide to Good Manufacturing Practice for Medicinal

More information

A.1 Contents file 4 to 5 A.1 (1)

A.1 Contents file 4 to 5 A.1 (1) Contents file 4 to 5 Contents file 4 to 5 A Information Contents file 4 to 5 A.2 Index file 4 to 5 A.3 List of Abbreviations A.4 Glossary A.5 Adress-Register A.6 References B Japanese Regulations B.1 MHW

More information

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice Version 8 (final) EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 Working

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. This document is for consultation until 11 December 2015

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. This document is for consultation until 11 December 2015 Ref. Ares(2015)3808922-15/09/2015 EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Medicinal Products Quality, Safety and Efficacy Brussels, [date] This document is for consultation until 11

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union Ref. Ares(2014)968036-28/03/2014 EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products quality, safety and efficacy Brussels, 28 March 2014 EudraLex

More information

PIC/S GUIDE TO GOOD PRACTICES FOR THE PREPARATION OF MEDICINAL PRODUCTS IN HEALTHCARE ESTABLISHMENTS

PIC/S GUIDE TO GOOD PRACTICES FOR THE PREPARATION OF MEDICINAL PRODUCTS IN HEALTHCARE ESTABLISHMENTS PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PE 010-3 1 October 2008 PIC/S GUIDE TO GOOD PRACTICES FOR THE PREPARATION OF MEDICINAL PRODUCTS IN HEALTHCARE ESTABLISHMENTS

More information

EU and FDA GMP Regulations: Overview and Comparison

EU and FDA GMP Regulations: Overview and Comparison THE QUALITY ASSURANCE JOURNAL, VOL. 2, 55 60 (1997) EU and FDA GMP Regulations: Overview and Comparison The increasing emphasis on global supply of drug products, as well as starting materials and investigational

More information

Good Manufacturing Practices Purpose and Principles of GMP. Tony Gould

Good Manufacturing Practices Purpose and Principles of GMP. Tony Gould Good Manufacturing Practices Purpose and Principles of GMP Tony Gould Why GMP? Provides a high level assurance that medicines are manufactured in a way that ensures their safety, efficacy and quality Medicines

More information

MANUFACTURE OF INVESTIGATIONAL MEDICINAL PRODUCTS

MANUFACTURE OF INVESTIGATIONAL MEDICINAL PRODUCTS ANNEX 13 MANUFACTURE OF INVESTIGATIONAL MEDICINAL PRODUCTS Introduction Medicinal products intended for research and development trials are not at present subject either to marketing or manufacturing Community

More information

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY. EudraLex. Volume 4

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY. EudraLex. Volume 4 EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Ref. Ares(2015)4234460-12/10/2015 Medicinal products quality, safety and efficacy Brussels, 12 October 2015 EudraLex Volume 4 EU Guidelines

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Public Health and Risk Assessment Medicinal Product quality, safety and efficacy Brussels, 16 August 2013 EudraLex The Rules Governing Medicinal

More information

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 25 October 2005 EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 EU

More information

MINISTRY OF HEALTH ORDINANCE

MINISTRY OF HEALTH ORDINANCE MINISTRY OF HEALTH 1799 Pursuant to Article 73, paragraph 2, Article 74, paragraph 2 and Article 89, paragraph 2 of the Medicinal Products Act (Official Gazette 76/2013), the Minister of Health hereby

More information

Brussels, C(2017) 8179 final. Guidelines

Brussels, C(2017) 8179 final. Guidelines EUROPEAN COMMISSION Brussels, 8.12.2017 C(2017) 8179 final Guidelines Detailed Commission guidelines on good manufacturing practice for investigational medicinal products for human use, pursuant to the

More information

Annex A2. Guidance on Process Validation Scheme for Aseptically Processed Products

Annex A2. Guidance on Process Validation Scheme for Aseptically Processed Products Annex A2 Guidance on Process Validation Scheme for Aseptically Processed Products 1 Table of content 1 PURPOSE... 3 2 SCOPE... 3 3 GENERAL INFORMATION... 3 4 INFORMATION NEEDED FOR ASEPTIC PROCESSES VALIDATION...

More information

EudraLex. Part I1 Chapter 6: Quality Control

EudraLex. Part I1 Chapter 6: Quality Control EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 EU Guidelines tofor Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use Part I1 Chapter 6: Quality

More information

Impact of EU GMPs on Australian GMP. Trevor Schoerie PharmOut

Impact of EU GMPs on Australian GMP. Trevor Schoerie PharmOut Impact of EU GMPs on Australian GMP Trevor Schoerie PharmOut Part I Basic Requirements for Medicinal Products Current TGA Version, 7 years out of date TGA are actively and publically talking about PE009-0813

More information

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PE 009-11 (Intro) 1 March 2014 GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PIC/S March 2014 Reproduction

More information

EUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS

EUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS EUROPEAN INDUSTRIAL PHARMACISTS GROUP Guidance on CPD for QUALIFIED PERSONS EIPG Guidance on CPD for QP Continuing Professional Development for Qualified Persons, Technical Directors and other Responsible

More information

GUIDELINES ON GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART 1

GUIDELINES ON GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART 1 GUIDELINES ON GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART 1 National Drug Authority Plot 46-48, Lumumba Avenue, P. O. Box 23096, Kampala, Uganda. Tel: +256-0414 - 255665/347391/2 Fax: +256-0414

More information

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART I

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART I PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PE 009-8 (Part I) 15 January 2009 GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART I PIC/S January 2009

More information

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART I

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART I PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PE 009-9 (Part I) 1 September 2009 GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART I PIC/S September

More information

Definitions given below apply to the words as used in this guide. They may have different meanings in other contexts.

Definitions given below apply to the words as used in this guide. They may have different meanings in other contexts. GLOSSARY GLOSSARY Definitions given below apply to the words as used in this guide. They may have different meanings in other contexts. AIR-LOCK An enclosed space with two or more doors, and which is

More information

GUIDELINES ON GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS ANNEXES

GUIDELINES ON GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS ANNEXES GUIDELINES ON GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS ANNEXES National Drug Authority Plot 46-48, Lumumba Avenue, P. O. Box 23096, Kampala, Uganda. Tel: +256-0414 - 255665/347391/2 Fax: +256-0414

More information

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART I

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART I PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PE 009-11 (Part I) 1 March 2014 GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART I PIC/S March 2014 Reproduction

More information

GUIDELINES ON THE PRINCIPLES OF GOOD DISTRIBUTION PRACTICE OF ACTIVE SUBSTANCES FOR MEDICINAL PRODUCTS FOR HUMAN USE

GUIDELINES ON THE PRINCIPLES OF GOOD DISTRIBUTION PRACTICE OF ACTIVE SUBSTANCES FOR MEDICINAL PRODUCTS FOR HUMAN USE PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 047-1 Annex 1 July 2018 GUIDELINES ON THE PRINCIPLES OF GOOD DISTRIBUTION PRACTICE OF ACTIVE SUBSTANCES FOR MEDICINAL

More information

(Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION

(Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION 21.3.2015 EN Official Journal of the European Union C 95/1 II (Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Guidelines of 19 March 2015 on

More information

Production of radiopharmaceuticals for clinical and research uses

Production of radiopharmaceuticals for clinical and research uses Production of radiopharmaceuticals for clinical and research uses The European perspective Philip Elsinga UMC Groningen The Netherlands The Rules European players in (radio ) pharmaceutical legislation

More information

European Medicines Agency Inspections

European Medicines Agency Inspections European Medicines Agency Inspections London, 3 March 2005 Doc. Ref. EMEA/INS/GMP/82801/2005 COMMUNITY BASIC FORMAT FOR MANUFACTURERS/ IMPORTERS AUTHORISATION 1. Authorisation number 2. Name of authorisation

More information

The rules governing medicinal products in the European Union. Presentation and content of the dossier Edition

The rules governing medicinal products in the European Union. Presentation and content of the dossier Edition The rules governing medicinal products in the European Union Volume 2B Notice to Applicants Medicinal products for human use Presentation and content of the dossier 1998 Edition EUROPEAN COMMISSION Directorate

More information

Journal of Chemical and Pharmaceutical Research

Journal of Chemical and Pharmaceutical Research Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research ISSN No: 0975-7384 CODEN(USA): JCPRC5 J. Chem. Pharm. Res., 2011, 3(6):88-98 Conduct of Inspections for Pharmaceutical Manufactures

More information

Quality Assurance in Pharmaceutical and Biotech Industries as Per Regulatory Guidelines

Quality Assurance in Pharmaceutical and Biotech Industries as Per Regulatory Guidelines Human Journals Review Article January 2017 Vol.:8, Issue:2 All rights are reserved by Chagi Venkatesh et al. Quality Assurance in Pharmaceutical Biotech Industries as Per Regulatory Guidelines Keywords:

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE: MANUFACTURE OF THE FINISHED DOSAGE FORM

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE: MANUFACTURE OF THE FINISHED DOSAGE FORM The European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit EMEA/CVMP/126/95 FINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE: MANUFACTURE OF THE

More information

PROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT

PROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT August 2010 RESTRICTED PROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT Please address any comments on this draft guideline

More information

GMP Inspection Deficiencies Review of Deficiencies Observed in 2013.

GMP Inspection Deficiencies Review of Deficiencies Observed in 2013. GMP Inspection Deficiencies 2013 Review of Deficiencies Observed in 2013. Executive Summary The most frequently encountered defect categories raised over the previous five years have remained relatively

More information

Regional GMP Strengthening Workshop for Indian Pharmaceutical Manufacturers and State Regulators

Regional GMP Strengthening Workshop for Indian Pharmaceutical Manufacturers and State Regulators Regional GMP Strengthening Workshop for Indian Pharmaceutical Manufacturers and State Regulators Focused on GMP in production of Active Pharmaceutical Ingredients and Oral Solid Dosage Forms Organized

More information

Qualified Persons in the Pharmaceutical Industry. Code of Practice. March 2008

Qualified Persons in the Pharmaceutical Industry. Code of Practice. March 2008 Qualified Persons in the Pharmaceutical Industry Code of Practice March 2008 Updated October 2009 Code of Practice for Qualified Persons 1. INTRODUCTION... 1 2. REGULATORY BASIS FOR THE QUALIFIED PERSON...

More information

Deficiencies found in Inspections and QP Responsibilities

Deficiencies found in Inspections and QP Responsibilities Deficiencies found in Inspections and QP Responsibilities Ciara Turley, HPRA Inspector QP Forum, Trinity College, Dublin 25 th April 2017 Dublin Key QP Responsibilities Chapter 1, 1.4 (xv) Medicinal products

More information

THE GMP HANDBOOK ANNEXES. g o o d m a n u fac t u r i n g p r ac t i c e. quality systems for the pharmaceutical industry.

THE GMP HANDBOOK ANNEXES. g o o d m a n u fac t u r i n g p r ac t i c e. quality systems for the pharmaceutical industry. THE GMP HANDBOOK g o o d m a n u fac t u r i n g p r ac t i c e quality systems for the pharmaceutical industry Ke y2 C om pl ia nc e AB by Anna Lundén ANNEXES Key2Compliance AB Annexes - Content Annexes

More information

Textvergleich. Verglichene Dokumente MEDIA3917.pdf. ICH_Q10_Step4.pdf

Textvergleich. Verglichene Dokumente MEDIA3917.pdf. ICH_Q10_Step4.pdf Textvergleich Verglichene Dokumente MEDIA3917.pdf ICH_Q10_Step4.pdf Übersicht 2270 Wort/Wörter hinzugefügt 1338 Wort/Wörter gelöscht 3558 Wort/Wörter übereinstimmend 157 Block/Blöcke übereinstimmend Blättern

More information

PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME. PI July 2018

PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME. PI July 2018 PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 045-1 1 July 2018 GUIDELINES ON THE FORMALISED RISK ASSESSMENT FOR ASCERTAINING THE APPROPRIATE GOOD MANUFACTURING

More information

Update to the Manufacturing Principles for Medicinal Products

Update to the Manufacturing Principles for Medicinal Products Update to the Manufacturing Principles for Medicinal Products Michel Lok, Head of Office Robyn Oatey, GMP Auditor, Medicines Office of Manufacturing Quality Therapeutic Goods Administration Introduction

More information

GOVERNMENT NOTICE NO. published on THE TANZANIA FOOD, DRUGS AND COSMETICS ACT (CAP 219) REGULATIONS. (Made under section 122(1)(o))

GOVERNMENT NOTICE NO. published on THE TANZANIA FOOD, DRUGS AND COSMETICS ACT (CAP 219) REGULATIONS. (Made under section 122(1)(o)) GOVERNMENT NOTICE NO. published on THE TANZANIA FOOD, DRUGS AND COSMETICS ACT (CAP 219) REGULATIONS (Made under section 122(1)(o)) THE TANZANIA FOOD, DRUGS AND COSMETICS (GOOD MANUFACTURING PRACTICE ENFORCEMENT)

More information

VOLUME 4 Good manufacturing practices ANNEX 13 Manufacture of investigational medicinal products JULY 2003

VOLUME 4 Good manufacturing practices ANNEX 13 Manufacture of investigational medicinal products JULY 2003 EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market : management & legislation for consumer goods Pharmaceuticals : regulatory framework and market authorisations Brussels, F2/BL D(2003) Revision

More information

Annex 14 WHO guidelines for drafting a site master file 136

Annex 14 WHO guidelines for drafting a site master file 136 World Health Organization WHO Technical Report Series, No.961, 2011 Annex 14 WHO guidelines for drafting a site master file 136 1. Introduction 2. Purpose 3. Scope 4. Content of site master fi le Appendix

More information

PIC/S GMP GUIDE FOR BLOOD ESTABLISHMENTS

PIC/S GMP GUIDE FOR BLOOD ESTABLISHMENTS PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PE 005-2 1 July 2004 PIC/S GMP GUIDE FOR BLOOD ESTABLISHMENTS PIC/S July 2004 Reproduction prohibited for commercial purposes.

More information

MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY On behalf of the Licensing Authority under The Medicines Act 1968

MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY On behalf of the Licensing Authority under The Medicines Act 1968 MIA(IMP) MIA(IMP) 15140 Version: 13 NUMBER: MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY On behalf of the Licensing Authority under The Medicines Act 1968 Manufacturer'S Authorisation - Investigational

More information

GMP for ATMP. Advanced Therapy Medicinal Products Key2Compliance AB

GMP for ATMP. Advanced Therapy Medicinal Products Key2Compliance AB GMP for ATMP Advanced Therapy Medicinal Products 2018 Key2Compliance AB 1 Content Background and regualtory requirements GMP Walkthrough Quality Risk Management 2018 Key2Compliance AB 2 Background and

More information

Supersedes Division Name Revision No. 0 Export Division Page No. 1 of 9

Supersedes Division Name Revision No. 0 Export Division Page No. 1 of 9 Page No. 1 of 9 Control Status 1.0 Purpose To lay down a procedure for conducting GMP inspection and report writing for issue of Written Confirmation for for medicinal products for human. 2.0 Scope This

More information

GMP MANUAL Contents. Contents (1) 1 Pharmaceutical Quality System (PQS) 2 Personnel

GMP MANUAL Contents. Contents (1) 1 Pharmaceutical Quality System (PQS) 2 Personnel GMP MANUAL GMP MANUAL 1 Pharmaceutical Quality System (PQS) 1.A Preface 1.B The road to a Pharmaceutical Quality System 1.C Introduction to the PQS 1.C.1 General requirements 1.C (1) 1.C.2 Documentation

More information

Q10 PHARMACEUTICAL QUALITY SYSTEM

Q10 PHARMACEUTICAL QUALITY SYSTEM Q10 PHARMACEUTICAL QUALITY SYSTEM This draft guidance, when finalized, will represent the Food and Drug Administration's (FDA's) current thinking on this topic. It does not create or confer any rights

More information

GMP MANUAL Contents. 1 Pharmaceutical Quality System (PQS)

GMP MANUAL Contents. 1 Pharmaceutical Quality System (PQS) GMP MANUAL GMP MANUAL 1 Pharmaceutical Quality System (PQS) 1.A Preface 1.B The road to a Pharmaceutical Quality System 1.C Introduction to the PQS 1.C.1 General requirements 1.C.2 Documentation 1.D Main

More information

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 14 December 2005 EudraLex The Rules Governing Medicinal Products in the European Union Volume 4

More information

5.19. EXTEMPORANEOUS PREPARATION OF RADIOPHARMACEUTICAL PREPARATIONS

5.19. EXTEMPORANEOUS PREPARATION OF RADIOPHARMACEUTICAL PREPARATIONS Pharmeuropa 26.2 1 Reference: NOTE ON THE GENERAL CHAPTER A first draft of this general chapter was presented in Pharmeuropa 23.4 with the title Compounding of radiopharmaceutical preparations. The chapter

More information

Overview and Introduction Annex 1 Revision

Overview and Introduction Annex 1 Revision Overview and Introduction Annex 1 Revision Paul Moody, Inspector Pharmig Current Hot Topics in Pharmaceutical Microbiology, Dublin May 30 th, 2018 Scope History Process of Revision Rationale for Revision

More information

Regulatory Requirements & Recent Changes, including expectations for APIs & IMPs

Regulatory Requirements & Recent Changes, including expectations for APIs & IMPs Regulatory Requirements & Recent Changes, including expectations for APIs & IMPs Neil Raw - GMP Inspector Richard Andrews - Operations Manager 11 th November 2008 Programme: Regulatory Requirements Neil

More information

DJ Cockburn Head of Manufacturing and Quality Compliance European Medicines Agency

DJ Cockburn Head of Manufacturing and Quality Compliance European Medicines Agency Introduction to EU Regulatory system and GMP Inspection system. The Qualified Person. DJ Cockburn Head of Manufacturing and Quality Compliance European Medicines Agency Any views expressed may not necessarily

More information

18.H Questionnaire for preparing GMP-inspections

18.H Questionnaire for preparing GMP-inspections Questionnaire for preparing -inspections Questionnaire for preparing -inspections Here you will find answers to the following questions: What questions are typically asked during inspections based on current

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Ref. Ares(2013)148102-05/02/2013 EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products quality, safety and efficacy Brussels, SANCO/D/6/SF/mg/ddg1.d.6(2013)179367

More information

Challenges of the regulatory body in implementing the legislations for the radiopharmaceuticals: efforts of IAEA

Challenges of the regulatory body in implementing the legislations for the radiopharmaceuticals: efforts of IAEA 2 nd Conference on Radioisotopes Production and Utilization And 11 th Cyclotron Research Workshop 26-27 March 2015 - Monastir (Tunisia) Challenges of the regulatory body in implementing the legislations

More information

MINISTRY OF HEALTH ORDINANCE

MINISTRY OF HEALTH ORDINANCE MINISTRY OF HEALTH 1800 Pursuant to Article 114, paragraph 2, Article 120, paragraph 3 and Article 127 of the Medicinal Products Act (Official Gazette 76/2013), the Minister of Health hereby issues the

More information

SITE MASTER FILE For MHRA

SITE MASTER FILE For MHRA ABC CO., LTD. For MHRA Prepared by Date Approved by Date Verified by Date Document No.: SMF, Version No: 01, Effective Date: 09/05/06 Document No.: SMF Version No.: 01 Effective Date: 09/05/06 Page 2 of

More information

GMP Requirements. Gabriel Kaddu, Senior GMP Specialist Promoting the Quality of Medicines Program (PQM) U.S. Pharmacopeial Convention (USP)

GMP Requirements. Gabriel Kaddu, Senior GMP Specialist Promoting the Quality of Medicines Program (PQM) U.S. Pharmacopeial Convention (USP) GMP Requirements Gabriel Kaddu, Senior GMP Specialist Promoting the Quality of Medicines Program (PQM) U.S. Pharmacopeial Convention (USP) 2016. ALL RIGHTS RESERVED. Outline GMP Procedures and standards

More information

QUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION

QUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PS/W 1/2011 2 Annexes 22 July 2011 QUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION PIC/S 2011 Reproduction

More information

Orange and Yellow Guides

Orange and Yellow Guides PHARMACY PREPARATION ACROSS EUROPE IS THERE A LEVEL PLAYING FIELD? Dr. Alison M.Beaney Regional Quality Assurance Specialist North-East England PHARMACY PREPARATION ACROSS EUROPE IS THERE A LEVEL PLAYING

More information

Safeguarding public health. Deficiency Database Figures April June 2009

Safeguarding public health. Deficiency Database Figures April June 2009 Deficiency Database Figures April June 9 Relevant Inspections Performed = Number of Critical Observations = 1 Number of Major Observations = 191 Slide Batch Release Complaint and Product Recall Sterility

More information

INSPECTION OF BIOTECHNOLOGY MANUFACTURES

INSPECTION OF BIOTECHNOLOGY MANUFACTURES PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 024-2 25 September 2007 AIDE-MEMOIRES INSPECTION OF BIOTECHNOLOGY MANUFACTURES PIC/S September 2007 Reproduction prohibited

More information

The World Bank. Aide Memoire for use during GMP inspections

The World Bank. Aide Memoire for use during GMP inspections The World Bank e for use during GMP inspections The World Bank Procurement of Health Sector Goods Contact persons: 0 1. General information about the manufacturer Name of manufacturer Physical address

More information

Regulation issued by the Federal Office for Safety in Health Care regarding the Schedule of Fees pursuant to the GESG

Regulation issued by the Federal Office for Safety in Health Care regarding the Schedule of Fees pursuant to the GESG Please be aware that we cannot guarantee the correctness of the translation. To make sure, you have the correct and complete version, please look at the German version of the official announcements of

More information

Regulation issued by the Federal Office for Safety in Health Care regarding the Schedule of Fees pursuant to the GESG

Regulation issued by the Federal Office for Safety in Health Care regarding the Schedule of Fees pursuant to the GESG Please be aware that we cannot guarantee the correctness of the translation. To make sure, you have the correct and complete version, please look at the German version of the official announcements of

More information

GUIDELINES FOR INTRODUCING A LOCALLY MANUFACTURED NEW PHARMACEUTICAL PRODUCT ON THE UGANDA MARKET

GUIDELINES FOR INTRODUCING A LOCALLY MANUFACTURED NEW PHARMACEUTICAL PRODUCT ON THE UGANDA MARKET GUIDELINES FOR INTRODUCING A LOCALLY MANUFACTURED NEW PHARMACEUTICAL PRODUCT ON THE UGANDA MARKET National Drug Authority Head Office Rumee Towers Plot 19, Lumumba Avenue P. O. Box 23096 Kampala, Uganda

More information

Good manufacturing practices

Good manufacturing practices ORIGINAL PAPER 1AR-10 ISBT Science Series (2009) 4, 6 10 Journal compilation 2009 International Society of Blood Transfusion Good manufacturing practices Blackwell Publishing Ltd A. Ahmed Quality Manager,

More information

A GUIDELINE ON DOSSIER REQUIREMENTS FOR TYPE I VARIATIONS November 1999

A GUIDELINE ON DOSSIER REQUIREMENTS FOR TYPE I VARIATIONS November 1999 EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Pharmaceuticals and cosmetics Final Revision 0 NOTICE TO APPLICANTS A GUIDELINE ON DOSSIER REQUIREMENTS FOR TYPE I VARIATIONS November 1999 This guideline

More information

Annex 4. Guidance on good manufacturing practices: inspection report. Background

Annex 4. Guidance on good manufacturing practices: inspection report. Background Annex 4 Guidance on good manufacturing practices: inspection report Background The need for revision of the Guidance on good manufacturing practices: inspection report (World Health Organization (WHO)

More information

GUIDANCE NOTE 37 MEDICAL GASES DATA INTEGRITY

GUIDANCE NOTE 37 MEDICAL GASES DATA INTEGRITY GUIDANCE NOTE 37 MEDICAL GASES DATA INTEGRITY 2017 GUIDANCE NOTE 37 MEDICAL GASES DATA INTEGRITY 2017 Copyright 2017 by British Compressed Gases Association. First printed 2017. All rights reserved. No

More information

Good practices in quality control in pharmaceutical industry - Overview of regulatory guidelines

Good practices in quality control in pharmaceutical industry - Overview of regulatory guidelines Review Article Good practices in quality control in pharmaceutical industry - Overview of regulatory guidelines Chagi Venkatesh*, S. B. Puranik ABSTRACT Good practices in quality control (QC) department

More information

PHYSICO-CHEMICAL, BIOLOGICAL OR MICROBIOLOGICAL TESTS OF MEDICINAL PRODUCTS

PHYSICO-CHEMICAL, BIOLOGICAL OR MICROBIOLOGICAL TESTS OF MEDICINAL PRODUCTS RADIOPHARMACEUTICALS Guideline Title Radiopharmaceuticals Legislative basis Directives 65/65/EEC, 75/318/EEC as amended, Directive 89/343/EEC Date of first adoption December 1990 Date of entry into June

More information

Explanatory note on fees payable to the European Medicines Agency

Explanatory note on fees payable to the European Medicines Agency 30 March 2015 EMA/167155/2014 Executive Director Explanatory note on s payable to the European Medicines Agency The s, exemptions and definitions described in this Explanatory Note apply as of 1 April

More information

ISO INTERNATIONAL STANDARD. Cosmetics Good Manufacturing Practices (GMP) Guidelines on Good Manufacturing Practices

ISO INTERNATIONAL STANDARD. Cosmetics Good Manufacturing Practices (GMP) Guidelines on Good Manufacturing Practices INTERNATIONAL STANDARD ISO 22716 First edition 2007-11-15 Corrected version 2008-05-15 Cosmetics Good Manufacturing Practices (GMP) Guidelines on Good Manufacturing Practices Cosmétiques Bonnes Pratiques

More information

New GMPs for Active Substances & Excipients. Presented by Eoin Hanley 4 July, 2016

New GMPs for Active Substances & Excipients. Presented by Eoin Hanley 4 July, 2016 New GMPs for Active Substances & Excipients Presented by Eoin Hanley 4 July, 2016 What we will cover in this session The changing landscape EC Guideline on principles of GDP of active substances Formalised

More information

EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 Good Manufacturing Practice

EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 Good Manufacturing Practice EUROPEAN COMMISSION EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 Good Manufacturing Practice Guidelines on Good Manufacturing Practice specific to Advanced Therapy Medicinal

More information

Draft Guidelines for Radiopharmacy

Draft Guidelines for Radiopharmacy Draft Guidelines for Radiopharmacy In the nuclear medicine laboratories (radiopharmacies) of nuclear medicine clinics in European hospitals, quality assurance varies from non-existent to good manufacturing

More information

Trinity College Dublin QP Forum 2017 Tuesday 25 th April

Trinity College Dublin QP Forum 2017 Tuesday 25 th April Trinity College Dublin QP Forum 2017 Tuesday 25 th April HPRA QUESTIONS & ANSWERS 1. What is the approach being taken for audit of contamination control strategies as per chapters 3 & 5? What is the current

More information

Aseptic Process Validation

Aseptic Process Validation Aseptic Process Validation IMB GMP Information Seminar 27 th September 2012 Gerard Sheridan, Inspector Date Insert on Master Slide Slide 1 Overview Guidance Best Practices Common Deficiencies Slide 2 Aseptic

More information

European Union (EU) Regulatory Trends in GMP. Clive Brading Tianjin, China September 23, 2009

European Union (EU) Regulatory Trends in GMP. Clive Brading Tianjin, China September 23, 2009 European Union (EU) Regulatory Trends in GMP Clive Brading Tianjin, China September 23, 2009 -2- Presentation Topics EU Background Inspections outside the EU EMEA Inspection Outcomes Dedicated Facilities

More information

Explanatory note on fees payable to the European Medicines Agency

Explanatory note on fees payable to the European Medicines Agency 09 December 2013 EMA/458574/2013 Executive Director Explanatory note on s payable to the European Medicines Agency The s, exemptions and definitions described in this Explanatory Note apply as of 1 January

More information

Regulatory Update. Greg McGurk, GMP Manager (acting) GMP Conference. 7 February 2017 Dublin

Regulatory Update. Greg McGurk, GMP Manager (acting) GMP Conference. 7 February 2017 Dublin Regulatory Update Greg McGurk, GMP Manager (acting) GMP Conference 7 February 2017 Dublin GMP Update Chapter 3 - Premises and Equipment (into operation since 1 March 2015) Chapter 5 - Production (into

More information

ANNEX 5 MANUFACTURE OF IMMUNOLOGICAL VETERINARY MEDICINAL PRODUCTS

ANNEX 5 MANUFACTURE OF IMMUNOLOGICAL VETERINARY MEDICINAL PRODUCTS ANNEX 5 MANUFACTURE OF IMMUNOLOGICAL VETERINARY MEDICINAL PRODUCTS Principle The manufacture of immunological veterinary medicinal products has special characteristics which should be taken into consideration

More information

Explanatory note on general fees payable to the European Medicines Agency

Explanatory note on general fees payable to the European Medicines Agency Explanatory note on general fees payable to the European Medicines Agency The fees, fee exemptions and definitions described in this explanatory note apply as of 1 June 2017 and are based on Council Regulation

More information

Unit 208 Assist with the manufacture and assembly of medicinal products

Unit 208 Assist with the manufacture and assembly of medicinal products Element 1 Element 2 Assist with the preparation and packaging Assist with the completion of the manufacturing and assembly process 341 342 Element 1 Element 2 Assist with the preparation and packaging

More information

UNICEF TECHNICAL REQUIREMENTS FOR MEDICAL DEVICES (MD)

UNICEF TECHNICAL REQUIREMENTS FOR MEDICAL DEVICES (MD) UNICEF TECHNICAL REQUIREMENTS FOR MEDICAL DEVICES (MD) A. Background January 2019 UNICEF Technical requirements for Medical Devices are the requirements that suppliers need to comply with, and that products

More information

The Pharmacovigilance Quality System. What is it?

The Pharmacovigilance Quality System. What is it? The Pharmacovigilance Quality System What is it? by Andy Blackman 12 November 2018 Are you starting to plan your first Marketing Authorisation Application? If yes, now is the time to start developing your

More information

Supply of aseptically - prepared doses of IMPs across legal boundaries. Edition 1. December 2017

Supply of aseptically - prepared doses of IMPs across legal boundaries. Edition 1. December 2017 Supply of aseptically - prepared doses of IMPs across legal boundaries Edition 1 December 2017 Endorsed and supported by: NHS Pharmaceutical Quality Assurance Committee 2017 with National Pharmacy Clinical

More information

Health Products and Food Branch Inspectorate Graham Spry Building, 3 rd Floor 250 Lanark Avenue Address Locator # 2003D OTTAWA, Ontario K1A 0K9 January 18, 2008 07-129000-175 TO: ALL INTERESTED PARTIES

More information

The interface between Good Clinical Practice and Good Manufacturing Practice

The interface between Good Clinical Practice and Good Manufacturing Practice 1 The interface between Good Clinical Practice and Good Manufacturing Practice your partner in compliance 1 The interface between GCP and GMP Generally, studies are designed and planned by physicians who

More information

Prequalification of Medicines Programme

Prequalification of Medicines Programme Prequalification of Medicines Programme SOP 408.4 Annex A WHO PUBLIC INSPECTION REPORT Finished Product Manufacturer WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer Part 1: General

More information

Legislative Framework and Scientific Guidance in European Assessment

Legislative Framework and Scientific Guidance in European Assessment Legislative Framework and Scientific Guidance in European Assessment Riccardo Luigetti Quality Assessors Training London 26 October 2009 1 Content of the presentation Scientific guidelines Other related

More information